Home > Clinical Trials

Saved trials

Completed
NCT03395639
Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease
168 Enrollment(s)
48 Study location(s)
Interventional (Phase III)
Cardiac Disease
Completed
NCT05262322
Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial Fibrillation
234 Enrollment(s)
8 Study location(s)
Observational
Atrial Fibrillation
Recruiting
NCT05359224
Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm
406 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Intracranial Aneurysm
Recruiting
NCT03568890
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
350 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Left Atrial Appendage Closure
Thrombosis
Stroke
TIA
Bleeding
Active, not recruiting
NCT04519944
Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
1,200 Enrollment(s)
66 Study location(s)
Observational
Non-valvular Atrial Fibrillation
Completed
NCT04459598
A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants
32 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Healthy Subjects
Drug-drug Interaction
Pharmacokinetics
Quizartinib
Recruiting
NCT05320627
Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation
120 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Non-Valvular Atrial Fibrillation
Completed
NCT04608344
Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants
27 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Rheumatoid Arthritis